MehmetSofuogluMD

Psychiatry • West Haven, CT

Associate Professor, Psychiatry, Yale University School of Medicine

Join to view full profile

Are you Dr. Sofuoglu?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 21 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
950 Campbell Ave
Bldg 36
West Haven, CT 06516
Phone+1 203-937-4809

Summary

Dr. Mehmet Sofuoglu, MD is a board certified psychiatrist in West Haven, Connecticut. He is currently licensed to practice medicine in Connecticut, Pennsylvania, and New York. He is affiliated with Veterans Affairs Connecticut Healthcare System and is an Associate Professor at Yale University School of Medicine.

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 1993 - 1995
University of MinnesotaResidency, Psychiatry, 1991 - 1993
Hacettepe University FOMClass of 1984

Certifications & Licensure

CA State Medical License 1993 - Present
CT State Medical License 2001 - 2025
PA State Medical License 2008 - 2008
NY State Medical License 2000 - 2002
MN State Medical License 1995 - 2000
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Effect of Progesterone on Smoking Behavior in Male and Female Smokers Start of enrollment: 2004 Sep 01
Completed
Phase 1
Cocaine Withdrawal and Pharmacotherapy Response Start of enrollment: 2007 Sep 01
Completed
Not Applicable
Galantamine Effects on Cognitive Function in Abstinent Cocaine Users Start of enrollment: 2007 Jun 01
Completed
Not Applicable
Varenicline and Nicotine Interactions in Humans (VA) Start of enrollment: 2007 Aug 01
Completed
Not Applicable
Atomoxetine Effects in Humans Start of enrollment: 2006 Jun 01
Completed
Phase 1, Phase 2
Effects of Atomoxetine Treatment in Humans Start of enrollment: 2006 Jun 01
Completed
Phase 1, Phase 2
GABA (Gamma Amino Butyric Acid) Medication for Tobacco Start of enrollment: 2007 Aug 01
Completed
Early Phase 1
Pharmacotherapy & CM for Opioid and Cocaine Dependence Start of enrollment: 2008 May 01
Completed
Phase 1, Phase 2
Dronabinol Interactions With Cognitive Enhancing Drug in Humans Start of enrollment: 2008 Sep 01
Completed
Early Phase 1
Sensitivity to Intravenous Nicotine: Genetic Moderators Start of enrollment: 2009 Jun 02
Completed
Phase 1
Galantamine Effects on Cognitive Function in Marijuana Users Start of enrollment: 2009 Aug 01
Completed
Phase 1
Progesterone for Postpartum Cocaine Relapse Start of enrollment: 2011 Feb 01
Completed
Not Applicable
Galantamine Effects on Nicotine Responses in Smokers Start of enrollment: 2010 Mar 01
Completed
Phase 1
Nicotine Reinforcement and Aversion in Young Adult Light Smokers Start of enrollment: 2017 Jan 04
Completed
Early Phase 1
Cognitive Effects of Atomoxetine in Humans: Genetic Moderators Start of enrollment: 2011 Dec 01
Completed
Not Applicable
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy Start of enrollment: 2011 Sep 01
Completed
Not Applicable
A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment Start of enrollment: 2012 Dec 01
Terminated
Not Applicable
A Study to Help People Quit Smoking. Start of enrollment: 2013 Dec 01
Completed
Not Applicable
The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users Start of enrollment: 2014 Mar 26
Completed
Not Applicable
The Effects of Minocycline in Humans Start of enrollment: 2013 Jul 08
Completed
Phase 1
The Effect of Nicotine Delivery Rate on Reinforcement Start of enrollment: 2017 Jan 05
Completed
Early Phase 1
Effects of Dronabinol in Opioid Maintained Patients Start of enrollment: 2019 May 31
Recruiting
Early Phase 1
Cognitive Function and Pain Threshold in People Who Are Methadone Maintained Start of enrollment: 2019 Jul 01
Completed
Early Phase 1
Smoking by IV Pulsed Nicotine Start of enrollment: 2019 Nov 15
Completed
Early Phase 1
Nicotine's Potential Abuse With Menthol Start of enrollment: 2021 Jun 28
Completed
Early Phase 1
Join now to see all

Publications & Presentations

PubMed

92 citations
Treatment outcome predictors for cocaine dependence.
James Poling, Thomas R. Kosten, Mehmet Sofuoglu
The American Journal of Drug and Alcohol Abuse. 2007-01-01
12 citations
Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only.
Joao P. De Aquino, Mehmet Sofuoglu, Elina A. Stefanovics, Robert Rosenheck
The American Journal of Drug and Alcohol Abuse. 2019-05-21
29 citations
Tobacco and alcohol use disorders: Evaluating multimorbidity.
R. Ross MacLean, Mehmet Sofuoglu, Robert A. Rosenheck
Addictive Behaviors. 2018-03-01

Press Mentions

Are Hormones Responsible for Your Addiction?June 11th, 2017

Grant Support

Cognitive Enhancement As A Target For Cocaine PharmacotherapyNational Institute On Drug Abuse2011–2012
Progesterone For Postpartum Cocaine RelapseNational Institute On Drug Abuse2010–2011
Human Laboratory Studies For Stimulant AddictionNational Institute On Drug Abuse2008–2011
Sensitivity To Intravenous Nicotine: Genetic ModeratorsNational Institute On Drug Abuse2009–2010
Cocaine Withdrawal And Pharmacotherapy ResponseNational Institute On Drug Abuse2007–2010
GABA Medications For Tobacco AddictionNational Institute On Drug Abuse2006–2009
GABA Medications And Cocaine Interaction In HumansNational Institute On Drug Abuse2007
GABA Medications And Cocaine Interactions In HumansNational Institute On Drug Abuse2006
Progestrone And The Effects Of NicotineNational Institute On Drug Abuse2003–2006
GABA Medications And Cocaine Interactions In HumansNational Institute On Drug Abuse2004–2005
Progesterone Treatment On Effects Of Stimulants In FemalesNational Center For Research Resources2000–2002
Stress Hormones And Human Cocaine Use--Effects Of LabetalolNational Center For Research Resources1998–1999
Stress Hormones And Human Cocaine UseNational Center For Research Resources1998–1999